This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/521937-moderna-vaccine-global-supply-demand/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| ‘A good problem to have’: There will be too much Covid-19 vaccine production in 2022, says Moderna boss | ‘A good problem to have’: There will be too much Covid-19 vaccine production in 2022, says Moderna boss |
| (about 2 months later) | |
| The CEO of pharmaceutical company Moderna has said Covid-19 vaccine production will overtake demand next year and while this is a “good problem” for the world, it is not ideal for companies making and selling the jabs. | The CEO of pharmaceutical company Moderna has said Covid-19 vaccine production will overtake demand next year and while this is a “good problem” for the world, it is not ideal for companies making and selling the jabs. |
| Speaking on Friday, Moderna's CEO Stephane Bancel told participants at a virtual event that his company was on track to produce a billion doses of their Covid-19 vaccine this year, enough for 500 million people. | Speaking on Friday, Moderna's CEO Stephane Bancel told participants at a virtual event that his company was on track to produce a billion doses of their Covid-19 vaccine this year, enough for 500 million people. |
| Bancel predicted that there would actually be too much supply globally in 2022, with Moderna itself raising production to 1.4 billion jabs. “Well, if anything that is a good problem to have in terms of dealing with the pandemic but it’s not a nice problem to have if you’re the one manufacturing the vaccine I guess,” he said. | Bancel predicted that there would actually be too much supply globally in 2022, with Moderna itself raising production to 1.4 billion jabs. “Well, if anything that is a good problem to have in terms of dealing with the pandemic but it’s not a nice problem to have if you’re the one manufacturing the vaccine I guess,” he said. |
| The Moderna boss said his firm was working hard to bring out a booster vaccine for late summer or fall as the need shifts to protecting against new variants of the virus.Global Covid-19 vaccine production has increased massively in 2021 and will continue as the year progresses. China claims it will have the capacity to produce 5 billion jabs by the end of the year, while India has said it will produce 100 million shots of its indigenous vaccine, Covaxin, alone by September. | The Moderna boss said his firm was working hard to bring out a booster vaccine for late summer or fall as the need shifts to protecting against new variants of the virus.Global Covid-19 vaccine production has increased massively in 2021 and will continue as the year progresses. China claims it will have the capacity to produce 5 billion jabs by the end of the year, while India has said it will produce 100 million shots of its indigenous vaccine, Covaxin, alone by September. |
| Britain, a relatively small country by population, will be manufacturing at least three vaccines, AstraZeneca, Novavax and Valneva, before the end of the year. | Britain, a relatively small country by population, will be manufacturing at least three vaccines, AstraZeneca, Novavax and Valneva, before the end of the year. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |